These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29048285)

  • 1. High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium.
    Guo Y; Tomich AD; McElheny CL; Cooper VS; Tait-Kamradt A; Wang M; Hu F; Rice LB; Sluis-Cremer N; Doi Y
    Emerg Infect Dis; 2017 Nov; 23(11):1902-1904. PubMed ID: 29048285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asp50Glu mutation in MurA results in fosfomycin resistance in Enterococcus faecium.
    Xin L; Hu Z; Han R; Xu X; Wang C; Li D; Guo Y; Hu F
    J Glob Antimicrob Resist; 2022 Sep; 30():50-55. PubMed ID: 35660662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the fosfomycin-resistance determinant, fosB3, in Enterococcus faecium clinical isolates from China.
    Chen C; Xu X; Qu T; Yu Y; Ying C; Liu Q; Guo Q; Hu F; Zhu D; Li G; Wang M
    J Med Microbiol; 2014 Nov; 63(Pt 11):1484-1489. PubMed ID: 25102907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel fosfomycin-resistant UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from a soil metagenome.
    Cheng G; Hu Y; Lu N; Li J; Wang Z; Chen Q; Zhu B
    Biotechnol Lett; 2013 Feb; 35(2):273-8. PubMed ID: 23143172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fosfomycin resistance gene fosB3 is located on a transferable, extrachromosomal circular intermediate in clinical Enterococcus faecium isolates.
    Xu X; Chen C; Lin D; Guo Q; Hu F; Zhu D; Li G; Wang M
    PLoS One; 2013; 8(10):e78106. PubMed ID: 24205114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms and epidemiology of fosfomycin resistance in enterococci isolated from patients at a teaching hospital in China, 2013-2016.
    Zhang X; Bi W; Chen L; Zhang Y; Fang R; Cao J; Zhou T
    J Glob Antimicrob Resist; 2020 Mar; 20():191-196. PubMed ID: 31422238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin.
    Perri MB; Hershberger E; Ionescu M; Lauter C; Zervos MJ
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):269-71. PubMed ID: 12007445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
    Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin.
    Shrestha NK; Chua JD; Tuohy MJ; Wilson DA; Procop GW; Longworth DL; Isada CM; Hall GS
    Scand J Infect Dis; 2003; 35(1):12-4. PubMed ID: 12685877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim resistance genes in vancomycin-resistant Enterococcus faecium clinical isolates from France.
    Cattoir V; Huynh TM; Bourdon N; Auzou M; Leclercq R
    Int J Antimicrob Agents; 2009 Oct; 34(4):390-2. PubMed ID: 19619988
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
    Das A; Banerjee T; Anupurba S
    Microb Drug Resist; 2020 Dec; 26(12):1509-1515. PubMed ID: 31794690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates.
    Cilli F; Pullukcu H; Aydemir S; Sipahi OR; Tasbakan M; Turhan A; Ulusoy S
    Int J Antimicrob Agents; 2008 Mar; 31(3):297-8. PubMed ID: 18180144
    [No Abstract]   [Full Text] [Related]  

  • 13. Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
    Descourouez JL; Jorgenson MR; Wergin JE; Rose WE
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1518-20. PubMed ID: 23263002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.
    Kawalec M; Gniadkowski M; Kedzierska J; Skotnicki A; Fiett J; Hryniewicz W
    J Clin Microbiol; 2001 Dec; 39(12):4274-82. PubMed ID: 11724832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.
    Elsner HA; Sobottka I; Feucht HH; Claussen M; Kaulfers PM; Laufs R; Mack D
    Chemotherapy; 2000; 46(2):104-10. PubMed ID: 10671760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin resistance among vancomycin-resistant enterococci owing to transfer of a plasmid harbouring the fosB gene.
    Qu TT; Shi KR; Ji JS; Yang Q; Du XX; Wei ZQ; Yu YS
    Int J Antimicrob Agents; 2014 Apr; 43(4):361-5. PubMed ID: 24388115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
    Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
    J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental survival of vancomycin-resistant Enterococcus faecium.
    Wagenvoort JH; De Brauwer EI; Penders RJ; Willems RJ; Top J; Bonten MJ
    J Hosp Infect; 2011 Mar; 77(3):282-3. PubMed ID: 21288596
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure and transfer of the vanA cluster in vanA-positive, vancomycin-susceptible Enterococcus faecium, and its revertant mutant.
    Jung YH; Lee YS; Lee SY; Yoo JS; Yoo JI; Kim HS; Kim O; Yu JY
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):148-50. PubMed ID: 25139845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Class IIa Bacteriocin Resistance in Enterococcus faecium.
    Geldart K; Kaznessis YN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.